571 Results (Page 23 of 23)
Spain Markets Research Reports
Spain Dental Endodontics Market Analysis
Spain Dental Endodontics Market was valued at $33.80 Mn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030, to $42.40 Mn by 2030. The key drivers of this industry include rising demand for tooth preservation, an aging population, and growing dental awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Spain Blood Disorder Therapeutics Market
Spain Blood Disorder Therapeutics Market valued at $259 Mn in 2022, projected to reach $428 Mn by 2030 with a 6.5% CAGR. The key drivers of the Spanish market include the aging population leading to a higher prevalence of blood-related issues, technological advancements like gene editing technologies creating new treatment opportunities, and evolving healthcare dynamics such as policies supporting early diagnosis and access to innovative medicines. The Spain Blood Disorder Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, Roche, Sanofi, Takeda, Bristol-Myers Squibb, Grifols, Gilead Sciences, Janssen Pharmaceuticals, BioMarin Pharmaceuticals etc, among various others.
Spain Clinical Nutrition Market Analysis
The Spain Clinical Nutrition Market was valued at $591.9 Mn in 2023 and is projected to grow at a CAGR of 4.34% from 2023 to 2023, to $796.9 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Grifols, Persan Farma, Adventia Pharma, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc among others.
Spain Breast Pump Market Report
The Spain Breast Pump Market was valued at $56.7 Mn in 2023 and is predicted to grow at a CAGR of 7.6% from 2023 to 2030, to $94.8 Mn by 2030. The key drivers of the market include the rising female workforce, enhanced features, and consumer awareness. The prominent players in the Spain Breast Pump Market are Medela, Elvie, Ameda, Avent, and Evenflo, among others.
Spain Cancer Induced Bone Disease Therapeutics Market
Spain Cancer Induced Bone Disease Therapeutics Market valued at $25 Mn in 2022, projected to reach $37 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include the increase in the incidence of cancers, unmet medical needs, and technological advancements. The industry is primarily dominated by players such as Advaxis, Takeda, Gradalis, Roche, Eli Lilly, Hikma, Bayer, and Amgen among others.
Spain Kidney Cancer Therapeutics Market Analysis
The Spain Kidney Cancer Therapeutics Market was valued at $121.40 Mn in 2023 and is predicted to grow at a CAGR of 3.86% from 2023 to 2030, to $158.25 Mn by 2030. The key drivers of this industry include the increasing prevalence of kidney cancer due to lifestyle and environmental factors, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, Novartis, Grupo Ferrer, Laboratorios Farmacéuticos Rovi, Roche, Bristol Myers Squibb, and AstraZeneca among others.
Spain Digital Biomarkers Market Analysis
Spain Digital Biomarkers Market was valued at $55.97 Mn in 2023 and is predicted to grow at a CAGR of 21.3% from 2023 to 2030, to $216.26 Mn by 2030. The key drivers of this industry include the high burden of chronic diseases, the advanced healthcare system, and the growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Spain Medication Access Programs Market Analysis
The Spain Medication Access Programs Market was valued at $105.9 Mn in 2023 and is predicted to grow at a CAGR of 13.6% from 2023 to 2030, to $258.7 Mn by 2030. The key drivers of this industry include the aging population, pharmaceutical innovation, and government support. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
Spain Cardiac Resynchronization Therapy Market
Spain Cardiac Resynchronization Therapy Market valued at $93 Mn in 2022, projected to reach $127 Mn by 2030 with a 4% CAGR. The worldwide increase in heart failure instances, propelled by aging demographics and cardiovascular diseases linked to lifestyle, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Boston Scientific, Medtronic, Biotronik, Siemens Healthineers, St. Jude Medical, Sorin Group, Edwards Lifesciences, LivaNova, and Terumo.
Spain Congestive Heart Failure Therapeutics Market Analysis
The Spain Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $199 Mn in 2022 to $289 Mn by 2030, with a CAGR of 4.8% during the forecast period of 2022-2030. The drivers include certain key factors like the aging population's increased risk, the prevalence of hypertension, dyslipidemia, and diabetes, along with government initiatives prioritizing chronic disease management and providing funding, fostering demand for innovative therapies, and stimulating market growth. The Spain Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Novartis, Boehringer Ingelheim, AstraZeneca, Bayer, Merck, Pfizer, Almirall, Grifols, PharmaMar, Zeltia, etc., among various others.
Spain Exosome Research Market Analysis
The Spain Exosome Research Market was valued at $3.3 Mn in 2023 and is projected to grow at a CAGR of 15% from 2023 to 2023, to $8.7 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Laminar Pharmaceuticals, Thermo Fisher Scientific, Medina, NX Pharmagen, Malvern Instruments among others.
Spain Physiotherapy Equipment Market Analysis
The Spain Physiotherapy Equipment Market was valued at $403.37 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $614.58 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, BTL Industries, EMS Physio Ltd., and Physiomed among others.
Spain Patient Adherence Programs Market Analysis
The Spain Patient Adherence Programs Market was valued at $250 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $750.5 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Spain Patient Adherence Programs Market are Atrys, Bayer, Boehringer Ingelhem, Novartis, and 3P Biopharmaceuticals, among others.
Spain LASIK Surgery Market Analysis
Spain LASIK Surgery Market was valued at $68.13 Mn in 2023 and is predicted to grow at a CAGR of 4.21% from 2023 to 2030, to $ 90.93 Mn by 2030. The key drivers of this industry include the rising prevalence, growing disposable income, and increasing awareness. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Spain Biosensors Market Analysis
The Spain Biosensors Market was valued at $557.8 Mn in 2023 and is predicted to grow at a CAGR of 7.0% from 2023 to 2030, to $895.7 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, emphasis on preventative care, and technological advancements. The prominent players of the Spain Biosensors Market are Villard Medical, Bio-Rad International, Masimo Corporation, Meridian Bioscience, and Biosensors International, among others.
Spain Medical Digital Imaging System Market Analysis
The Spain Medical Digital Imaging System Market was valued at $588.65 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $957.68 Mn by 2030. The key drivers of this industry include growing healthcare expenditure, advancement in technology, and the aging population. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Spain Hemodialysis Vascular Grafts Market Analysis
Spain Hemodialysis Vascular Grafts Market was valued at $4.04 Bn in 2023 and is predicted to grow at a CAGR of 4.1% from 2023 to 2030, to $5.36 Bn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, government investment in healthcare, and the aging population. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Spain Breastfeeding Accessories Market Analysis
Spain Breastfeeding Accessories Market was valued at $48.44 Mn in 2023 and is predicted to grow at a CAGR of 5.80% from 2023 to 2030, to $71.88 Mn by 2030. The key drivers of this industry include a high breastfeeding initiation rate, government initiatives, and advancements in product technology. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
Spain Hospital Market Analysis
The Spain Hospital Market was valued at $106.14 Bn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $166.03 Bn by 2030. The key drivers of this industry are rise in geriatric population, technological advancements, and medical tourism. The key players in the industry are Quirónsalud, Hospital Ruber Internacional, HM Hospitales, and Hospital HLA Moncloa among others.
Spain Graft-versus-Host Disease (GvHD) Therapeutics Market Analysis
The Spain GvHD Therapeutics Market was valued at $48.25 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $77.99 Mn by 2030. The growth in the Spanish market is driven by various factors like the rise in chronic GvHD cases, advanced technology, increasing awareness, government support, and the increasing prevalence of blood diseases. The major competitors in the market are Merck, Sanofi, Pfizer, Novartis, Mallinckrodt, Incyte, Abbott, and Takeda among others.
Spain Central Nervous System (CNS) Therapeutics Market Analysis
The Spain Central Nervous System (CNS)Therapeutics Market was valued at $4.053 Bn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $6.173 Bn by 2030. The key drivers of this industry include the surge in the prevalence of CNS disorders, increased healthcare expenditure, and technological advancements in the industry. The industry is primarily dominated by players such as AbbVie, Pfizer, Eli Lilly, Grunenthal, Teva, Biogen, and Novartis among others.
